EDGAR Filing Documents for 0001104659-22-082802

Form 8-K - Current report:

SEC Accession No. 0001104659-22-082802

Filing Date

2022-07-26

Accepted

2022-07-26 16:31:04

Documents

Period of Report

2022-07-22

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2221834d1_8k.htm iXBRL	8-K	45143
2	EXHIBIT 1.1	tm2221834d1_ex1-1.htm	EX-1.1	255059
3	EXHIBIT 3.1	tm2221834d1_ex3-1.htm	EX-3.1	101868
4	EXHIBIT 4.3	tm2221834d1_ex4-3.htm	EX-4.3	106170
5	EXHIBIT 99.1	tm2221834d1_ex99-1.htm	EX-99.1	12616
6	EXHIBIT 99.2	tm2221834d1_ex99-2.htm	EX-99.2	10780
	Complete submission text file	0001104659-22-082802.txt		833710

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	kprx-20220722.xsd	EX-101.SCH	3048
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	kprx-20220722_lab.xml	EX-101.LAB	34476
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	kprx-20220722_pre.xml	EX-101.PRE	22605
11	EXTRACTED XBRL INSTANCE DOCUMENT	tm2221834d1_8k_htm.xml	XML	3834

Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105

Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869

KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)